STTK
Shattuck Labs Inc

643
Mkt Cap
$204.39M
Volume
870,268.00
52W High
$3.38
52W Low
$0.6922
PE Ratio
-3.17
STTK Fundamentals
Price
$3.23
Prev Close
$3.23
Open
$3.20
50D MA
$2.17
Beta
1.71
Avg. Volume
120,302.47
EPS (Annual)
-$1.49
P/B
2.19
Rev/Employee
$130,022.73
Loading...
Loading...
News
all
press releases
Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy
HC Wainwright upgrades Shattuck Labs on confidence in SL-325, a DR3 antibody aiming for stronger, durable IBD treatment amid TL1A concerns.read more...
Benzinga·11d ago
News Placeholder
More News
News Placeholder
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shattuck Labs, Inc. (NASDAQ:STTK - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six brokerages that are covering the stock, Marketbeat.com reports. One investment analyst...
MarketBeat·19d ago
News Placeholder
Shattuck Labs (NASDAQ:STTK) Issues Earnings Results
Shattuck Labs (NASDAQ:STTK - Get Free Report) announced its earnings results on Thursday. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.01. The...
MarketBeat·1mo ago
News Placeholder
What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?
Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·2mo ago
News Placeholder
Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Zacks·3mo ago
News Placeholder
Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?
Shattuck Labs (STTK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·3mo ago
News Placeholder
GXO Logistics, Momentus, Shattuck Labs: 3 Stocks Retail Investors Are Most Bullish On Today
Potential sale talks, NASA contracts, and insider buybacks are sparking strong interest
Stocktwits·1y ago
News Placeholder
Shattuck Labs Stock Nosedives As Lead Cancer Therapy Fails: Retail Enthusiasm Evaporates
The Austin-based biotech firm also revealed plans to cut 40% of its workforce as part of a broader restructuring
Stocktwits·1y ago

Latest STTK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.